Marvell Technology presents its optical technology approach for AI and cloud data centers at OFC 2024 in San Diego, and receives positive analyst ratings.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
CEO of Micron Technology, Inc met with China's Minister of Commerce to discuss future development. China supports Micron's investments and plans to cater to Chinese consumers. Recent reports show China's effort to replace US technology with domestic alternatives.
Stifel covers Summit Therapeutics, highlighting ivonescimab's promise in phase 3 lung cancer trials, potential market expansion worth billions, and a buy rating with $8 target. Updates from Akeso in 2024 and a $5 billion deal add to the optimism, signaling potential share price growth ahead.
Mizuho analyst initiates Hilton Grand Vacations coverage with a Buy rating, foreseeing FY24 EBITDA of $1.24B, citing revenue synergies and owned inventory benefits.